跳至主要内容
临床试验/NCT02108236
NCT02108236Unknown不适用

Effectiveness and Safety of Acupuncture for Obesity and Over-weight People

Heilongjiang University of Chinese Medicine1 个研究点 分布在 1 个国家目标入组 110 人开始时间: 2014年5月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
110
试验地点
1
主要终点
body mass index(BMI)

研究概览

简要总结

To determine the efficacy and safety of acupuncture for obesity and overweight people in China.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • The individuals is phlegm-dampness constitution and female.
  • Age is between 18 and 45 years.
  • BMI is between 24 and
  • The individuals voluntarily sign the informed consent form.
  • The individuals live in Harbin City of China.

排除标准

  • Secondary obesity, eg:pituitary diseases, hypothalamic disorder, hypothyroidism, pancreatic diseases,hyperadrenocorticism, postmenopausal obesity etc.
  • The individuals with server cardiovascular and cerebrovascular diseases and cancer.
  • Having therapy for obesity in the last three months.
  • The individuals do not adhere to the treatment or are with other treatments.
  • Female individuals with pregnancy, lactation and planning a pregnancy in the two months.
  • Critical patients or patients combined with liver and kidney damage.
  • Individuals with visual and auditory memory disorders or psychosis.

结局指标

主要结局

body mass index(BMI)

时间窗: 2 month after treatment

次要结局

  • Blood sugar(2 month after treatment)
  • Triglycerides(2 month after treatment)
  • waist-to-hip ratio (WHR)(2 month after treatment)
  • Total cholesterol(2 month after treatment)
  • High-density lipoprotein cholesterol(2 month after treatment)
  • Low-density lipoprotein cholesterol(2 month after treatment)

研究者

发起方
Heilongjiang University of Chinese Medicine
申办方类型
Other
责任方
Principal Investigator
主要研究者

Wang Ling Shu

the head of institute of chinese medicine and translational science of First Affiliated Hospital

Heilongjiang University of Chinese Medicine

研究点 (1)

Loading locations...

相似试验